Development and characterization of solid dispersion-based orodispersible tablets of cilnidipine
Abstract Background Cilnidipine, a calcium channel blocker, is the first-line drug for hypertension and belongs to Biopharmaceutics Classification System II. To mitigate its extensive first-pass metabolism and improve patient compliance, the present study was performed to develop and characterize so...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SpringerOpen
2022-06-01
|
| シリーズ: | Beni-Suef University Journal of Basic and Applied Sciences |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1186/s43088-022-00259-3 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|